Large-scale testing (Phase 3)Study completedNCT03480802
What this trial is testing
Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults Infected With Human Immunodeficiency Virus (HIV) (V114-018)
Who this might be right for
Pneumococcal Infections
Merck Sharp & Dohme LLC 302